France to OK therapeutic cloning?

Leading researchers hopeful that a ban on somatic cell nuclear replacement will be lifted soon

Written byJane Burgermeister
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

One of a group of leading French scientists who have called on the government to lift a ban on human therapeutic cloning, told The Scientist this week that he is hopeful that the law will soon be changed.

Marc Peschanski from INSERM, the French national institute for health and medical research, and nine other leading researchers submitted a "petition" last week to the French National Assembly, calling for regulations covering human embryo research to be changed to allow therapeutic cloning.

Peschanski said France was in danger of falling behind in an important area of biomedical research because of the ban. He called the current law out-dated.

"Experiments in South Korea and the United Kingdom have made therapeutic cloning a scientific tool," he said. "My own team would benefit from access to therapeutic cloning techniques to find breakthroughs in medical research for illnesses, such as diabetes, Parkinson's and Alzheimer's disease."

He ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Meet the Author

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies